Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group (Q45000486)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group |
scientific article |
Statements
1 reference
Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group (English)
1 reference
Jacques Bonneterre
1 reference
Henri Roché
1 reference
Pierre Kerbrat
1 reference
Pierre Fumoleau
1 reference
Marie-Josèphe Goudier
1 reference
Pierre Fargeot
1 reference
Philippe Montcuquet
1 reference
Pierre Clavère
1 reference
Jean-Claude Barats
1 reference
Alain Monnier
1 reference
Corinne Veyret
1 reference
Jean Datchary
1 reference
Isabelle Van Praagh
1 reference
Isabelle Chapelle-Marcillac
1 reference
1 August 2004
1 reference
1 reference
Identifiers
1 reference